Page:United States Statutes at Large Volume 124.djvu/4003

 124 STAT. 3977 PUBLIC LAW 111–356—JAN. 4, 2011 ‘‘(2) state the specific roles and responsibilities of each relevant National Drug Control Program agency for imple- menting the strategy; ‘‘(3) identify the specific resources required to enable the relevant National Drug Control Program agencies to implement the strategy; and ‘‘(4) reflect the unique nature of small communities along the international border between the United States and Canada, ongoing cooperation and coordination with Canadian law enforcement authorities, and variations in the volumes of vehicles and pedestrians crossing through ports of entry along the international border between the United States and Canada. ‘‘(d) SPECIFIC CONTENT RELATED TO CROSS-BORDER INDIAN RES- ERVATIONS.—The Northern Border Counternarcotics Strategy shall include— ‘‘(1) a strategy to end the illegal trafficking of drugs to or through Indian reservations on or near the international border between the United States and Canada; and ‘‘(2) recommendations for additional assistance, if any, needed by tribal law enforcement agencies relating to the strategy, including an evaluation of Federal technical and finan- cial assistance, infrastructure capacity building, and interoper- ability deficiencies. ‘‘(e) LIMITATION.— ‘‘(1) IN GENERAL.—The Northern Border Counternarcotics Strategy shall not change the existing agency authorities and this section shall not be construed to amend or modify any law governing interagency relationships. ‘‘(2) LEGITIMATE TRADE AND TRAVEL.—The Northern Border Counternarcotics Strategy shall be designed to promote, and not hinder, legitimate trade and travel. ‘‘(f) TREATMENT OF CLASSIFIED OR LAW ENFORCEMENT SEN- SITIVE INFORMATION.— ‘‘(1) IN GENERAL.—The Northern Border Counternarcotics Strategy shall be submitted in unclassified form and shall be available to the public. ‘‘(2) ANNEX.—The Northern Border Counternarcotics Strategy may include an annex containing any classified information or information the public disclosure of which, as determined by the Director or the head of any relevant National Drug Control Program agency, would be detrimental to the Public information.